Solving Issues Like Labor Shortages and Business Succession! Nikkei Healthcare February Issue Campaign Underway – Nikkei Medical

News Highlights

Nikkei Healthcare’s February issue features a special report focusing on solutions to pressing issues faced by medical institutions, such as labor shortages and business succession, and is currently running a gift campaign. For medical M&A and business succession, it is essential to consider schemes unique to medical corporations, such as the transfer of equity interests, changes in membership, and fund returns. Furthermore, a fair valuation of the business, taking into account medical profits, fixed assets, licenses, staff, and patient base, is crucial, as is ongoing support for stabilizing the new system after the deal is closed.

M&A Medical Editorial Department’s Perspective

While the campaign in Nikkei Healthcare’s February issue superficially promotes “problem-solving,” the underlying reality is a severe “depletion of options” in healthcare institution management. In particular, due to lack of successors and the difficulty of maintaining regional healthcare, cases requiring more fundamental management strategies such as M&A-based business transfers or corporate integrations are increasing. For example, a clinic in a rural area with an aging physician population might be integrated into a nearby medical corporation group, opening up avenues for securing specialists and introducing the latest equipment. In such circumstances, understanding the unique schemes of medical corporations, such as equity interest transfers and fund returns, and being able to select the most suitable method for one’s own institution will likely determine the future success or failure of its management.

Points Highlighted by This News

• The simultaneous progression of labor shortages and business succession poses the greatest risk to the management of medical institutions.
• Understanding the unique schemes of medical corporations (equity interest transfer, change of membership, fund return) is key to smooth succession.
• Valuation of intangible assets such as licenses and patient base, not just medical profits, is essential for M&A deal closure.
• The presence or absence of a follow-up system after M&A closure affects the stable operation of the new system.

Practical Questions Arising from This News

• What are the specific differences between equity interest transfer and change of membership in the business succession of my institution?
• When calculating a fair enterprise value through M&A, how are the patient base and staff retention rates evaluated?
• What specific support does post-succession follow-up entail?

If You Feel “Should I Consult Too?”

While M&A may not be the sole solution to issues such as labor shortages and lack of successors that your institution faces, it is certainly worth considering as one of the options. Especially if you are seriously considering the sustainability of regional healthcare and the future of your staff and patients, it is essential to conduct an objective analysis of the current situation and future simulations with experts. First, let’s organize your institution’s situation and begin gathering information on what options may be available.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, with a complete success fee system. We handle consultations with strict confidentiality. Free consultation here